Patients who started treatment earlier, with CD4 counts of between 200 and 350 cells/mm3, had significantly fewer deaths and fewer cases of TB compared with those who had deferred treatment to less than 200 cells/mm3 or when an AIDS-defining illness occurred. This evidence concerns the gene CD4 and AIDS.